REG - Eco Animal Health Gp - Deferred Share Option Awards
13/12/2022 16:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221213:nRSM5871Ja&default-theme=true
RNS Number : 5871J Eco Animal Health Group PLC 13 December 2022
13 December 2022
ECO Animal Health Group plc
("ECO" or the "Company")
Deferred Share Option Awards to Executive Director & PDMRs
ECO Animal Health Group plc announces that on 12 December 2022, deferred
nominal cost share options were granted under the Company's Deferred Bonus
Plan ("DBS") over 45,606 ordinary shares in the Company (representing
approximately 0.07 percent of the Company's issued share capital) to an
Executive Director and members of the Company's Executive Leadership Team
("ELT") listed below. These awards relate to the deferral of 33% and 20% of
the annual bonus for Executive Directors and members of ELT respectively
earned in respect of the Company's financial year ended 31 March 2022.
Name Position Number of Deferred Share Options
Chris Wilks Chief Financial Officer 4,309
Hafid Benchaoui Head of Global Research and Development 3,666
Andrew Buglass Business Unit Head - China & Japan 6,872
Seamus Long Global Director of Operations 2,260
Jordi Mora Global Technical Services Director 4,507
Piotr Postepski Global Director of Sales 14,926
Oscar Romero-Galindo Head of Global Marketing 9,066
As indicated in the Circular to shareholders dated 4 February 2021, the DBS
has been established to allow the Remuneration Committee to require a
significant part of the annual bonuses paid to Executive Directors and senior
management to be deferred in exchange for an award of nominal cost options
which vest after 3 years.
For further information please contact:
020 8447 8899
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
IFC Advisory 020 3934 6630
Graham Herring
Zach Cohen
Singer Capital Markets (Nominated Adviser & Joint Broker) 020 7496 3000
Phil Davies
George Tzimas
Investec (Joint Broker) 020 7597 5970
Gary Clarence
Daniel Adams
Carlo Spingardi
Equity Developments 020 7065 2692
Hannah Crowe
Matt Evans
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.
PDMR Notification - ECO DBS Deferred Share Option Awards
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name 1. Chris Wilks
2. Hafid Benchaoui
3. Andrew Buglass
4. Seamus Long
5. Jordi Mora
6. Piotr Postepski
7. Oscar Romero-Galindo
2. Reason for the notification
a. Position/status 1. Chief Financial Officer
2. Head of Global Research and Development
3. Business Unit Head - China & Japan
4. Global Director of Operations
5. Global Technical Services Director
6. Global Director of Sales
7. Head of Global Marketing
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Eco Animal Health Group Plc
b. LEI 2138009XN9DJ3YP70B55
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Options over ordinary shares of 5p each.
Financial instrument, type of instrument
Identification code GB0032036807
b. Nature of the transaction Award of nominal cost share options under the Company's DBS.
c. Price(s) and volume(s) Numbers 1 to 7 in the left-hand column correspond to the relevant PDMR as
detailed in boxes 1a and 2a above.
Price(s) Volume(s)
1. 5p 4,309
2. 5p 3,666
3. 5p 6,872
4. 5p 2,260
5. 5p 4,507
6. 5p 14,926
7. 5p 9,066
d. Aggregated information
Aggregated volume
Price n/a
e. Date of the transaction 12 December 2022
f. Place of the transaction Outside a trading venue.
d.
Aggregated information
Aggregated volume
Price
n/a
e.
Date of the transaction
12 December 2022
f.
Place of the transaction
Outside a trading venue.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGPGMCPUPPGAWRecent news on ECO Animal Health
See all newsREG - Eco Animal Health Gp Schroders PLC - Holding(s) in Company
AnnouncementREG - Eco Animal Health Gp - Director/PDMR Shareholding
AnnouncementREG - Eco Animal Health Gp - Trading Update
AnnouncementREG - Eco Animal Health Gp - R&D Day
AnnouncementREG - Eco Animal Health Gp - Submission of Marketing Authorisation Application
Announcement